HomeCompareNWHM vs MRK

NWHM vs MRK: Dividend Comparison 2026

NWHM yields 22.25% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NWHM wins by $27.0K in total portfolio value
10 years
NWHM
NWHM
● Live price
22.25%
Share price
$8.99
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$83.7K
Annual income
$8,507.23
Full NWHM calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NWHM vs MRK

📍 NWHM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNWHMMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NWHM + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NWHM pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NWHM
Annual income on $10K today (after 15% tax)
$1,890.99/yr
After 10yr DRIP, annual income (after tax)
$7,231.15/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $1,097.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NWHM + MRK for your $10,000?

NWHM: 50%MRK: 50%
100% MRK50/50100% NWHM
Portfolio after 10yr
$70.3K
Annual income
$9,152.68/yr
Blended yield
13.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NWHM
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NWHM buys
0
MRK buys
0
No recent congressional trades found for NWHM or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNWHMMRK
Forward yield22.25%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$83.7K$56.8K
Annual income after 10y$8,507.23$9,798.13
Total dividends collected$50.2K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NWHM vs MRK ($10,000, DRIP)

YearNWHM PortfolioNWHM Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,925$2,224.69$11,206$366.19+$1.7KNWHM
2$16,517$2,687.24$12,650$502.35+$3.9KNWHM
3$20,882$3,209.41$14,407$694.19+$6.5KNWHM
4$26,136$3,792.24$16,585$967.82+$9.6KNWHM
5$32,402$4,435.86$19,342$1,363.89+$13.1KNWHM
6$39,809$5,139.47$22,913$1,947.19+$16.9KNWHM
7$48,497$5,901.35$27,662$2,823.89+$20.8KNWHM
8$58,611$6,718.94$34,159$4,173.35+$24.5KNWHM
9$70,303$7,588.90$43,337$6,308.80+$27.0KNWHM
10$83,731$8,507.23$56,776$9,798.13+$27.0KNWHM

NWHM vs MRK: Complete Analysis 2026

NWHMStock

The New Home Co., Inc. designs, constructs and sells homes. The company is headquartered in Aliso Viejo, California and currently employs 322 full-time employees. The firm focuses on the design, construction and sale of consumer-driven homes in various metropolitan areas within certain markets in California and Arizona, including coastal Southern California, the San Francisco Bay area, metro Sacramento and the greater Phoenix area. The firm's segments include homebuilding and fee building. The homebuilding operations consist of divisions in Northern California, Southern California and its division in Arizona, which is established through the purchase of lots in an unconsolidated joint venture. The firm is focused on building and selling homes for its own account. The company is focused on identifying sites and creating communities that allow it to design, construct and sell consumer-driven single-family detached and attached homes in major metropolitan areas in coastal Southern California, the San Francisco Bay area, metro Sacramento and the greater Phoenix area.

Full NWHM Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NWHM vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NWHM vs SCHDNWHM vs JEPINWHM vs ONWHM vs KONWHM vs MAINNWHM vs JNJNWHM vs ABBVNWHM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.